TRPV4 and nervous system disorder: In 2010, three groups, Landouré et al., Deng et al., and Auer-Grumbach et al., independently reported that heterozygous TRPV4 mutations cause these neurological diseases, SP-SMA/HMSN IIC/CMT 2C [38,39,40].